Adult bacterial myositis: report of a single-center series of 26 cases

  • Fernando Gallucci Department of Internal Medicine, Cardarelli Hospital, Napoli, Italy.
  • Ilaria Ronga Department of Internal Medicine, Cardarelli Hospital, Napoli, Italy.
  • Francesco Di Pietto Department of Radiology, Cardarelli Hospital, Napoli, Italy.
  • Gerardino Amato Microbiology Unit, Cardarelli Hospital, Napoli, Italy.
  • Rosario Buono Department of Internal Medicine, Cardarelli Hospital, Napoli, Italy.
  • Generoso Uomo | gene.uomo@virgilio.it Department of Internal Medicine, Cardarelli Hospital, Napoli, Italy.

Abstract

Bacterial infections involving muscle are quite uncommon and generally require specific predisposing factors. Bacterial myositis is more rarely described in the typical kind of patients observed in Internal Medicine (presence of multiple co-morbidities, partial/limited immune-deficiency, advanced age). Twenty-six patients suffering from bacterial myositis (8 women and 18 men; mean age 58.5 years, range 27-82) observed in a single Internal Medicine Unit were reported. Muscles involved were ileopsoas, thigh, paravertebral, gluteus, calf, forearm and rectus abdomen. Simultaneous presence of arthritis was registered in 17 patients and all patients presented relevant comorbidity. Main cultured bacteria were Staphylococcus aureus, Escherichia coli, other Gram-negative bacteria, Streptococcus spp. Multi-drug-resistance was observed in 14 out 26 (53.8%). Computed tomography, ultrasound and magnetic resonance imaging were utilized for diagnostic purposes. Antibiotic treatment was administered to all patients. Surgical debridement and drainage were performed in 12 patients; 7 patients were treated with percutaneous aspiration and drainage. At discharge, relevant functional impairment was present in 17 patients (65.3%). Four patients died (in-hospital mortality 7.6%, global mortality at three months 15.3%). Management of bacterial myositis is difficult and its prognosis is poor. In the near future, this demanding infection will be more frequently observed in Internal Medicine setting as comorbidity, which is very often the main characteristic of these patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Author Biography

Generoso Uomo, Department of Internal Medicine, Cardarelli Hospital, Napoli
Director of Internal Medicimne Unit

References

Stevens DL. Necrotizing soft tissue infections. Curr Treat Opt Infect Dis 2000; 2: 359-68

Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microb Rev 2008; 21: 473-94

Brook I. Microbiology and management of soft tissue and muscle infections. Int. J Surg 2007; 30:1–11

Miller NJ, Duncan RD, Huntley JS. The conservative management of primary pyomyositis abscess in children: case series and review of the literature. Scott Med J 2011; 56: 181-7

Falagas ME, Rafailidis PI, Kapaskelis A, Peppas G. Pyo-myositis associated with hematological malignancy: case report and review of the literature. Int J Infect Dis 2008; 12:120–125

Vigil KJ, Johnson JR, Johnston BD et al. Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 2010: 50:374-80

Roberts JA, Abdul-Aziz MH, Lipman J et al. Individualised antibiotic dosing for patients who are critically ill: challenges an potential solutions. Lancet Infect Dis 2014; 14: 498-509

Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet 2005; 44: 1099-34

Christopher-Stine, LP, Plotz H. Myositis: an update on pathogenesis. Curr Opin Rheumatol 2004;16:700–706

Small LN, Ross JJ. Tropical and temperate pyomyositis. Inf Dis Clin N Am 2005; 19: 981-9

Pannaraj PS, Hulten KG et al. Infective pyomyositis and myositis in children in the era of community- acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006; 43:953–60

Brown EL, Dumitrescu O, Thomas D et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 2009; 15:156–64

Tseng CW, Kyme P, Low J et al. Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury.

PLoS ONE 2009; 4: e6387

Saders HS, Farrell DI, Jones RN. Antimicrobial susceptibility of GRAM-positive cocci isolated from skin and skin-structure infections in European medical centres. Int J Antimicrob Agents 2010; 36: 28-32

Eckmann C, Lawson W, Nathwani D et al. Antibiotic treatment across Europe in patients with complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents 2014; 44: 56-64

ECDC-annual epidemiological report 2014. Antimicrobial resistance and healthcare-associated infections. April 2015; www.ecds.europa.eu

Burdette SD, Watkins RR, Wong KK et al. Staphylococcus aureus pyomyositis compared with non-Staphylococcus aureus pyomyositis. J. Infect 2012; 64: 507-12

Block AA, Marshall C, Ratcliffe A, Athan E. Staphylococcal pyomiositis in a temperate region: epidemiology and modern management. Med J Aust 2008; 189: 323-5

Adjipavlou M, Butt DA, McAllister J. Primary pyomiositis: an unusual presentation in an older patient with no recognized risk factors. BMJ Case Rep 2012 ; Feb 25; doi:10.1136/bcr.12.2011.5342

Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother 2010; 66 (suppl 3): 35-44

Zadroga RJ, Zylla D, Cawcutt K et al. Pneumococcal pyomiositis: report of 2 cases and review of literature. Clin Infect Dis 2012; 55: e12-7

Chiu SK, Chang FY. Pyomiositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia. Int J Infect Dis 2008; 13: e85-7

Sharma U, Schwan WR, Agger WA. Escherichia coli pyomiositis in an immunocompromised host. Wisc Med J 2011; 110: 182-4

Masferrer-Pino A, Cavanilles-Walker JM, Olive-Marques A. Pyomiositis of the inner thigh muscles due to Escherichia coli in a young patient with severe aplastic anemia. Reumatol Clin 2014; 10:22-24

Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother 2010; 65(s3): 11-24

Yu CW, Hsiao JK, Hsu CY, Shih TT. Bacterial pyomyositis: MRI and clinical correlation. Magn Reson Imaging 2004 ; 22:1233-41

Theodorou SJ, Theodorou DJ, Resnick D. MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases. Emerg Radiol. 2007;14:89-96

Struk DW, Munk PL, Lee MJ et al. Imaging of soft tissue infections. Radiol Clin North Am 2001; 39 :277-303

Lalam RK, Cassar-Pullicino VN, Tins BJ. Magnetic resonance imaging of appendicular musculoskeletal infection. Top Magn Reson Imaging 2007; 18: 177-91

Bierry G, Huang AJ, Chang CY et al. MRI findings of treated bacterial septic arthritis. Skeletal Radiol 2012;41:1509-16

Ali SZ, Srinivasan S, Peh WC. MRI in necrotizing fasciitis of the extremities. Br J Radiol 2014 Jan; 87 (1033):20130560 .

Published
2016-09-30
Info
Issue
Section
Case Reports
Keywords:
Bacterial myositis, pyomyositis, magnetic resonance imaging, antibiotics, co-morbidity.
Statistics
  • Abstract views: 1244

  • PDF: 659
  • HTML: 894
How to Cite
Gallucci, F., Ronga, I., Di Pietto, F., Amato, G., Buono, R., & Uomo, G. (2016). Adult bacterial myositis: report of a single-center series of 26 cases. Italian Journal of Medicine, 10(3), 226-233. https://doi.org/10.4081/itjm.2016.667